StonvexLoading…
StonvexStonvexStonvexCore line items from CLH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.03B | $5.89B | $5.41B | $5.17B |
Operating Income | $673.37M | $670.23M | $612.44M | $634.75M |
Net Income | $390.97M | $402.30M | $377.86M | $411.74M |
EPS (Diluted) | $7.28 | $7.42 | $6.95 | $7.56 |
Total Assets | $7.62B | $7.38B | $6.38B | $6.13B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $826.32M | $687.19M | $444.70M | $492.60M |
Free Cash Flow OCF − CapEx | $441.81M | $345.53M | $312.25M | $281.16M |
Shares Outstanding | 52.87M | 53.83M | 53.93M | 54.06M |